Stephen Pethen

Stephen Pethen has extensive experience in drug metabolism and pharmacokinetics (DMPK) and related fields, currently serving as Director of DMPK and Screening at KalVista Pharmaceuticals, Inc. since March 2012. Prior to this role, Stephen held the position of Team Leader - DMPK at KalVista Pharmaceuticals, Inc. and worked as Principal Scientist - DMPK at Vantia Therapeutics from March 2008 to March 2012. Stephen's career also includes a role as Principal Scientist - ADMET at Ferring Pharmaceuticals from April 2005 to March 2008 and a position as Scientist at Covance from September 1994 to April 2005.